Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News CareDx Inc CDNA

Healthcare Biotechnology
CareDx, Inc. is a precision medicine solutions company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based... see more

Recent & Breaking News (NDAQ:CDNA)

JACC Publication Guides Use of CareDx's HeartCare Transplant Rejection Surveillance in Clinical Practice

Business Wire January 26, 2023

CareDx Fosters Transplant Innovation as Distinguished Founder's Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium

Business Wire January 11, 2023

CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022

Business Wire January 9, 2023

CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA

Business Wire December 30, 2022

New ISHLT Guidelines Support Use of CareDx's HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients

Business Wire December 21, 2022

CAREDX INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA

PR Newswire December 16, 2022

Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors

GlobeNewswire December 14, 2022

CareDx Announces $50 Million Stock Repurchase Program

Business Wire December 6, 2022

CAREDX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of CareDx, Inc. - CDNA

Business Wire December 5, 2022

Independent Prospective Study Defines Reference Range for CareDx's AlloSure for Long-Term Lung Transplant Surveillance

Business Wire December 1, 2022

Grabar Law Office Investigates Claims on Behalf of Shareholders of CareDx, Inc. (CDNA)

Newsfile November 30, 2022

CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community

Business Wire November 11, 2022

CareDx To Participate in Upcoming Investor Conferences

Business Wire November 4, 2022

CareDx Reports Third Quarter 2022 Results

Business Wire November 3, 2022

CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week

Business Wire November 2, 2022

Independent Longitudinal Study Finds CareDx's AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients

Business Wire November 1, 2022

CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System

Business Wire October 27, 2022

CareDx to Report Third Quarter 2022 Financial Results

Business Wire October 26, 2022

CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients

Business Wire October 26, 2022

CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting

Business Wire October 25, 2022